130 related articles for article (PubMed ID: 23863262)
61. Predictive value of serum gamma-glutamyltransferase levels in patients with hepatocellular carcinoma.
Sun L; Wang R; Gao FY; Li YX; Geng MF; Chen JL; Ye XQ; Li XS; Yang X; Wan G; Yang ZY; Wang XB
Neoplasma; 2017; 64(3):444-452. PubMed ID: 28253724
[TBL] [Abstract][Full Text] [Related]
62. Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M; Kidani H; Hattori N; Ishii M
Gastroenterol Jpn; 1985 Jun; 20(3):209-15. PubMed ID: 2412927
[TBL] [Abstract][Full Text] [Related]
63. Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume.
Wang MH; Ji Y; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Bi AH; Tan YS
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):467-76. PubMed ID: 19406586
[TBL] [Abstract][Full Text] [Related]
64. Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival.
Agarwal PD; Phillips P; Hillman L; Lucey MR; Lee F; Mezrich JD; Said A
J Clin Gastroenterol; 2017 Oct; 51(9):845-849. PubMed ID: 28877082
[TBL] [Abstract][Full Text] [Related]
65. Portal Vein Thrombosis and Markers of Inflammation in Hepatocellular Carcinoma.
Carr BI; Guerra V; Donghia R
J Gastrointest Cancer; 2020 Dec; 51(4):1141-1147. PubMed ID: 32851544
[TBL] [Abstract][Full Text] [Related]
66. Inverse relationship between cirrhosis and massive tumours in hepatocellular carcinoma.
Sarpel U; Ayo D; Lobach I; Xu R; Newman E
HPB (Oxford); 2012 Nov; 14(11):741-5. PubMed ID: 23043662
[TBL] [Abstract][Full Text] [Related]
67. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
Ince V; Carr BI; Bag HG; Koc C; Usta S; Ersan V; Baskiran A; Sahin TT; Yilmaz S
Int J Biol Markers; 2020 Jun; 35(2):91-95. PubMed ID: 32436751
[TBL] [Abstract][Full Text] [Related]
68. Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.
Giuliante F; De Rose AM; Guerra V; Ardito F; Nuzzo G; Carr BI
J Gastrointest Cancer; 2013 Sep; 44(3):329-35. PubMed ID: 23912605
[TBL] [Abstract][Full Text] [Related]
69. Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Carr BI; Pancoska P; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Jun; 41(3):406-414. PubMed ID: 25023357
[TBL] [Abstract][Full Text] [Related]
70. Hepatocellular carcinoma in the noncirrhotic liver.
Gaddikeri S; McNeeley MF; Wang CL; Bhargava P; Dighe MK; Yeh MM; Dubinsky TJ; Kolokythas O; Lalwani N
AJR Am J Roentgenol; 2014 Jul; 203(1):W34-47. PubMed ID: 24951228
[TBL] [Abstract][Full Text] [Related]
71. Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1215-1219. PubMed ID: 33006073
[TBL] [Abstract][Full Text] [Related]
72. Platelet-related phenotypic patterns in hepatocellular carcinoma patients.
Carr BI; Lin CY; Lu SN
Semin Oncol; 2014 Jun; 41(3):415-21. PubMed ID: 25023358
[TBL] [Abstract][Full Text] [Related]
73. Comprehensive clinicopathologic study of alpha fetoprotein-expression in a large cohort of patients with hepatocellular carcinoma.
Ridder DA; Weinmann A; Schindeldecker M; Urbansky LL; Berndt K; Gerber TS; Lang H; Lotz J; Lackner KJ; Roth W; Straub BK
Int J Cancer; 2022 Mar; 150(6):1053-1066. PubMed ID: 34894400
[TBL] [Abstract][Full Text] [Related]
74. A novel prognostic index-neutrophil times γ-glutamyl transpeptidase to lymphocyte ratio (NγLR) predicts outcome for patients with hepatocellular carcinoma.
Li J; Liao Y; Suo L; Zhu P; Chen X; Dang W; Liao M; Qin L; Liao W
Sci Rep; 2017 Aug; 7(1):9229. PubMed ID: 28835713
[TBL] [Abstract][Full Text] [Related]
75. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
[TBL] [Abstract][Full Text] [Related]
76. Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
Sharieff S; Burney IA; Salam A; Siddiqui T
J Pak Med Assoc; 2001 Mar; 51(3):123-4. PubMed ID: 11381826
[TBL] [Abstract][Full Text] [Related]
77. Thrombocytosis and hepatocellular carcinoma.
Carr BI; Guerra V
Dig Dis Sci; 2013 Jun; 58(6):1790-6. PubMed ID: 23314854
[TBL] [Abstract][Full Text] [Related]
78. Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Sakar B; Ustuner Z; Karagol H; Aksu G; Camlica H; Aykan NF
Am J Clin Oncol; 2004 Oct; 27(5):489-93. PubMed ID: 15596917
[TBL] [Abstract][Full Text] [Related]
79. Ultrasonographic characteristics of small hepatocellular carcinoma.
Higashi T; Tobe K; Asano K; Ikeda H; Ohsawa T; Iwasaki Y; Nouso K; Shinji N; Morimoto Y; Satoh Y
Acta Med Okayama; 1988 Jun; 42(3):151-7. PubMed ID: 2456671
[TBL] [Abstract][Full Text] [Related]
80. Platelets contribute to growth and metastasis in hepatocellular carcinoma.
Bihari C; Rastogi A; Shasthry SM; Bajpai M; Bhadoria AS; Rajesh S; Mukund A; Kumar A; Sarin SK
APMIS; 2016 Sep; 124(9):776-86. PubMed ID: 27457354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
